Get started
Author

Qiang Wang

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib
2018 · Y. Wang, T. Jiang, et al. · Annals of Oncology · 207
Reprogramming astrocytic NDRG2/NF-κB/C3 signaling restores the diabetes-associated cognitive dysfunction
2023 · Tao Jiang, Yansong Li, et al. · EBioMedicine · 53
PDF
Electroacupuncture pretreatment preserves telomerase reverse transcriptase function and alleviates postoperative cognitive dysfunction by suppressing oxidative stress and neuroinflammation in aged mice
2023 · Wei Wang, Chen Chen, et al. · CNS Neuroscience & Therapeutics · 45
PDF
Dexmedetomidine attenuates sleep deprivation-induced inhibition of hippocampal neurogenesis via VEGF-VEGFR2 signaling and inhibits neuroinflammation
2023 · Shuyue Zhang, Ying Zhang, et al. · Biomedicine & Pharmacotherapy · 34
Comparative efficacy of cryoablation versus robot-assisted partial nephrectomy in the treatment of cT1 renal tumors: a systematic review and meta-analysis
2024 · HuiYu Gao, Lin Zhou, et al. · BMC Cancer · 9
PDF
Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer
2024 · Guohui Zhang, Qiang Wang, et al. · Biochemical and Biophysical Research Communications · 9
An Oncolytic Vaccinia Virus Expressing Aphrocallistes Vastus Lectin Modulates Hepatocellular Carcinoma Metabolism via ACSS2/TFEB-Mediated Autophagy and Lipid Accumulation
2025 · Qiang Wang, Simeng Zhou, et al. · Marine Drugs · 5
PDF
1296P A phase II study to evaluate the efficacy and safety of BB-1701 in advanced or metastatic NSCLC patients with HER2 mutation/amplification
2024 · C. Zhou, X. Li, et al. · Annals of Oncology · 3
PDF
P83.03 Efficacy of Camrelizumab (SHR-1210) Plus Apatinib in Advanced NSCLC with EGFR Mutation
2021 · G. Gao, Y. Wang, et al. · Journal of Thoracic Oncology · 3
PDF
1267P Efficacy of camrelizumab (SHR-1210) plus apatinib as second-line treatment for advanced squamous NSCLC
2020 · G. Gao, Y. Wang, et al. · Annals of Oncology · 2
Recent and speculative remote myocardial trauma: a case series
2024 · Zhijuan Lu, Xiaocong Zhang, et al. · European Heart Journal - Case Reports · 1
840P Famitinib malate plus camrelizumab for recurrent platinum-resistant ovarian/fallopian tube/primary peritoneal cancer and advanced cervical cancer: An open-label, multicenter phase II study
2020 · L. Xia, Q. Zhou, et al. · Annals of Oncology · 1
Hyperfractionated Radiotherapy-Induced Lymphocyte Alterations and Prognostic Implications in Small Cell Lung Cancer
2025 · Qiang Wang, Zhao Jiang, et al. · SSRN Electronic Journal
Trimethylamine N-oxide / SREBP2 pathway is involved in sleep deprivation-induced cognitive dysfunction through regulating astrocytic cholesterol metabolism
2023 · Shan Zhu, Yue Wang, et al. · Research Square
PDF
P83.01 Updated Survival and Biomarker Analysis of Camrelizumab and Apatinib in Previously Treated pts of Advanced Non-Squamous NSCLC
2021 · S. Ren, Y. Wang, et al. · Journal of Thoracic Oncology
PDF
Works count: 15
Citation count: 372
H-index: 6
I10-index: 4
Year
Topic
Type